Matsubayashi Y, Yoshida A, Suganami H, Oe M, et al. Predictors of haemoglobin levels and of changes in these levels, focusing on anaemia and polycythaemia after administration of the sodium-glucose cotransporter-2 inhibitor tofogliflozin. Diabetes Obes Metab 2022;24:2469-2473.
PMID: 35979908